A citation-based method for searching scientific literature

Howard Sofen, Stacy Smith, Robert T Matheson, Craig L Leonardi, Cesar Calderon, Carrie Brodmerkel, Katherine Li, Kim Campbell, Stanley J Marciniak, Yasmine Wasfi, Yuhua Wang, Philippe Szapary, James G Krueger. J Allergy Clin Immunol 2014
Times Cited: 193



Edmund Lee, William L Trepicchio, Judith L Oestreicher, Debra Pittman, Frank Wang, Francesca Chamian, Madhav Dhodapkar, James G Krueger. J Exp Med 2004
Times Cited: 662




List of shared articles



Times cited

The Relapse of Psoriasis: Mechanisms and Mysteries.
Danning Tian, Yuping Lai. JID Innov 2022
1


A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab.
Feras M Ghazawi, Farhan Mahmood, Leon Kircik, Yves Poulin, Marc Bourcier, Ronald Vender, Marni C Wiseman, Charles Lynde, Ivan V Litvinov. Front Med (Lausanne) 2021
4

Guselkumab in the treatment of moderate-to-severe plaque psoriasis.
Cristina López-Sánchez, Lluís Puig. Immunotherapy 2020
3

Characterization of a reliable cell-based reporter gene assay for measuring bioactivities of therapeutic anti-interleukin-23 monoclonal antibodies.
Jing Huang, Lan Wang, Chuanfei Yu, Zhihao Fu, Chunyu Liu, Hongmei Zhang, Kaiqin Wang, Xiao Guo, Junzhi Wang. Int Immunopharmacol 2020
2

The Immunobiology of the Interleukin-12 Family: Room for Discovery.
Elia D Tait Wojno, Christopher A Hunter, Jason S Stumhofer. Immunity 2019
164


Determination of IL-23 Pharmacokinetics by Highly Sensitive Accelerator Mass Spectrometry and Subsequent Modeling to Project IL-23 Suppression in Psoriasis Patients Treated with Anti-IL-23 Antibodies.
Ting-Ting Zhang, Junli Ma, Kenneth R Durbin, Timothy Montavon, Susan E Lacy, Gary J Jenkins, Stella Doktor, J Cory Kalvass. AAPS J 2019
3

Skin Patterning in Psoriasis by Spatial Interactions between Pathogenic Cytokines.
Lee Ringham, Przemyslaw Prusinkiewicz, Robert Gniadecki. iScience 2019
3

A new class of biologic agents facing the therapeutic paradigm in psoriasis: anti-IL-23 agents.
Annalisa Tonini, Bruno Gualtieri, Salvatore Panduri, Marco Romanelli, Andrea Chiricozzi. Expert Opin Biol Ther 2018
15

Scanning the Immunopathogenesis of Psoriasis.
Andrea Chiricozzi, Paolo Romanelli, Elisabetta Volpe, Giovanna Borsellino, Marco Romanelli. Int J Mol Sci 2018
121

Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints.
Marie-Astrid Boutet, Alessandra Nerviani, Gabriele Gallo Afflitto, Costantino Pitzalis. Int J Mol Sci 2018
88

Shifting the focus - the primary role of IL-23 in psoriasis and other inflammatory disorders.
M J Gooderham, K A Papp, C W Lynde. J Eur Acad Dermatol Venereol 2018
46

Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab.
Todd Wechter, Abigail Cline, Steven R Feldman. Ther Clin Risk Manag 2018
8